Availability of Program Application Instructions for the Protection and Advocacy Systems Network To Expand COVID-19 Vaccine Access for People With Disabilities, 18538-18541 [2021-07292]

Download as PDF 18538 Federal Register / Vol. 86, No. 67 / Friday, April 9, 2021 / Notices obtained from: https://iupdate.dnb.com/ iUpdate/viewiUpdateHome.htm. C. Intergovernmental Review Executive Order 12372, Intergovernmental Review of Federal Programs, is not applicable to these grant applications. IV. Submission Information 1. Letter of Assurance To receive funding, eligible entities must provide a Letter of Assurance containing all the information outlined in Section III above. Letters of Assurance should be addressed to: Alison Barkoff, Acting Administrator and Assistant Secretary for Aging, Administration for Community Living, 330 C Street SW, Washington, DC 20201. Letters of Assurance should be submitted electronically via email to your ACL program officer. The following table identifies the designated program officer against each of the 10 ACL regions: ACL regions Peter Nye—Program Officer ............................. Veronica Hogan ................................................. Jennifer Martin ................................................... Kimball Gray ...................................................... 2. Submission Dates and Times To receive consideration, Letters of Assurance must be submitted by 11:59 p.m. Eastern Time on April 23, 2021. Letters of Assurance should be submitted electronically via email and have an electronic time stamp indicating the date/time submitted. VII. Agency Contacts 1. Programmatic and Submission Issues Direct programmatic inquiries to Program Officer found in the table in ‘‘Section IV. Submission Information.’’ 2. Submission Issues Direct inquiries regarding submission of the Letters of Assurance to Program Officer found in the table in ‘‘Section IV. Submission Information.’’ Dated: April 5, 2021. Alison Barkoff, Acting Administrator and Assistant Secretary for Aging. Email/phone Region II • NY, NJ, PR, VI Region V • IL, IN, MI, MN, OH, WI Region X • AK, ID, OR, WA Region I • CT, MA, ME, NH, RI, VT Region III • DC, DE, MD, PA, VA, WV Region VII • IA, KS, MO, NE Region IV • AL, FL, GA, KY, MS, NC, SC, TN Region VI • AR, LA, OK, NM, TX Region VIII • CO, MT, UT, WY, ND, SD Region IX • CA, NV, AZ, HI, GU, CNMI, AS peter.nye@acl.hhs.gov; 202–795–7606. DEPARTMENT OF HEALTH AND HUMAN SERVICES grants to disability networks to provide critical services to help communities combat COVID–19. A leading priority of this joint effort is to ensure vaccines are equally accessible to the disability population. Approximately 61 million adults living with in the US have a disability, representing approximately 26 percent of the adult population. People with disabilities may have an increased risk for contracting COVID–19 based on where they live or the services they receive. Some people with disabilities live in group settings, which places them at higher risk for acquiring COVID–19 in comparison to people without disabilities. People with disabilities may also require close contact with direct service providers, including personal care attendants or other care providers, who help with activities of daily living. Moreover, many people with disabilities have underlying health conditions (e.g., diabetes, heart disease, and obesity) that increases the risk of severe illness due to COVID–19. In addition, research also found that people with Down Syndrome are significantly more likely to be hospitalized from COVID–19 than the general population. Administration for Community Living Availability of Program Application Instructions for the Protection and Advocacy Systems Network To Expand COVID–19 Vaccine Access for People With Disabilities Title: Expanding Disabilities Network’s (Protection and Advocacy Systems) Access to COVID–19 Vaccines. Announcement Type: Initial. Statutory Authority: Subtitle C of the Developmental Disabilities Assistance and Bill of Rights Act of 2000 (DD Act). Catalog of Federal Domestic Assistance (CFDA) Number: 93.630. DATES: The deadline date for the submission of the Expanding Disabilities Network’s (Protection and Advocacy Systems) Access to COVID– 19 Vaccines is 11:59 p.m. Eastern Time April 23, 2021. SUPPLEMENTARY INFORMATION: [FR Doc. 2021–07290 Filed 4–8–21; 8:45 am] I. Funding Opportunity Description BILLING CODE 4154–01–P The Administration for Community Living (ACL) announced a new funding opportunity to increase vaccine access for people with disabilities. With funding and partnership support from the Centers for Disease Control and Prevention (CDC), ACL is providing VerDate Sep<11>2014 17:45 Apr 08, 2021 Jkt 253001 PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 veronica.hogan@acl.hhs.gov; 202–795–7365. jennifer.martin@acl.hhs.gov; 202–795–7399. kimball.gray@acl.hhs.gov; 202–795–7353. E:\FR\FM\09APN1.SGM 09APN1 18539 Federal Register / Vol. 86, No. 67 / Friday, April 9, 2021 / Notices There are increasing reports of barriers of unequal access in communities to vaccinate people with disabilities. For example, some people with disabilities may experience difficulties scheduling appointments, communicating, obtaining accessible transportation or require direct support services to attend vaccination appointments. Others living in the community may be isolated or unable to leave their home and may require inhome vaccination. This funding opportunity is designed to breakdown those barriers to expand vaccine access in communities. Examples of activities consistent with the purpose of this funding are the following: • Education about the importance of receiving a vaccine; • Identifying people unable to independently travel to a vaccination site; • Helping with scheduling a vaccine appointment; • Arranging or providing accessible transportation; • Providing companion/personal support; • Reminding people of the second vaccination appointment if needed; and/or • Providing technical assistance to local health departments or other entities on vaccine accessibility. Awards authorized under Subtitle C of the DD Act to the Protection and Advocacy Systems (P&As) shall be provided funding under this opportunity. Award recipients will be required to submit annual progress reports in the form of a written summary on the activities conducted, challenges, successes, and lessons learned. In addition, to show impact of the grant awards, the grantee will include the number of people served or impacted by the services provided, against each of the activities chosen to be implemented. To be eligible to receive this grant, the grantee must submit a Letter of Assurance to ACL containing all the assurances required, (see below, ‘‘Section III. Eligibility Criteria and Other Requirements’’ and ‘‘Section IV. Submission Information’’). P&As that do not complete assurance requirements below, or otherwise indicate no desire to receive funds will be excluded from receiving funds. ACL may establish ad hoc dates based on the need of the COVID–19 response, e.g., to meet unanticipated issues related to COVID–19 and/or to allow impacted eligible applicants that missed the cutoff date to submit an application for consideration. ACL intends to issue initial notices of award as applications VerDate Sep<11>2014 17:45 Apr 08, 2021 Jkt 253001 are received prior to the application due date to address urgent COVID–19 response needs. Second notices of award are planned after the actual number of applicants is finalized. II. Award Information 1. Funding Instrument Type These awards will be made in the form of formula grants to P&As. 2. Anticipated Total Funding per Budget Period Under this program announcement, ACL intends to make grant awards to each State, Territory, the District of Columbia, and the Native American Consortium. Awards made under this announcement have an estimated start date of April 1, 2021 and an estimated end date of December 31, 2022, for a 20month budget and performance period. The total available funding for this opportunity is $4,000,000. Funding will be distributed based on the state/ territory population. There are no costsharing nor match requirements. Below are the projected award amounts: Projected amount Jurisdiction Alabama ................................ Alaska ................................... Arizona .................................. Arkansas ............................... California ............................... Colorado ............................... Connecticut ........................... Delaware ............................... District of Columbia .............. Florida ................................... Georgia ................................. Hawaii ................................... Idaho ..................................... Illinois .................................... Indiana .................................. Iowa ...................................... Kansas .................................. Kentucky ............................... Louisiana .............................. Maine .................................... Maryland ............................... Massachusetts ...................... Michigan ............................... Minnesota ............................. Mississippi ............................ Missouri ................................ Montana ................................ Nebraska .............................. Nevada ................................. New Hampshire .................... New Jersey ........................... New Mexico .......................... New York .............................. North Carolina ...................... North Dakota ........................ Ohio ...................................... Oklahoma ............................. Oregon .................................. Pennsylvania ........................ Rhode Island ........................ PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 $50,203 39,713 74,525 39,713 404,556 58,963 39,713 39,713 39,713 219,907 108,710 39,713 39,713 129,744 68,930 39,713 39,713 45,744 47,598 39,713 61,901 70,571 102,254 57,743 39,713 62,840 39,713 39,713 39,713 39,713 90,943 39,713 199,181 107,386 39,713 119,683 40,515 43,185 131,077 39,713 Jurisdiction Projected amount South Carolina ...................... South Dakota ........................ Tennessee ............................ Texas .................................... Utah ...................................... Vermont ................................ Virginia .................................. Washington ........................... West Virginia ........................ Wisconsin ............................. Wyoming ............................... American Samoa .................. Guam .................................... Northern Marianas ................ Puerto Rico ........................... Virgin Islands ........................ Native American ................... 52,717 39,713 69,923 296,883 39,713 39,713 87,394 77,967 39,713 59,615 39,713 21,246 21,246 21,246 39,713 21,246 21,246 Total .................................. 4,000,000 III. Eligibility Criteria and Other Requirements 1. Eligible Entities The eligible entity for these awards is the agency designated as a P&A per the DD Act. 2. Other Requirements A. Letter of Assurance A Letter of Assurance is required to be submitted by the eligible entity in order to receive an award. The Letter of Assurance must include the following: 1. Assurance that the award recipient is the agency or entity designated as P&A per the DD Act. 2. Assurance that funds will supplement and not supplant existing P&A funding. 3. Assurance that funds will be spent in ways consistent with the purpose of the funding in carrying out one or more of the following activities: • Education about the importance of receiving a vaccine; • Identifying people unable to independently travel to a site; • Helping with scheduling a vaccine appointment; • Arranging or providing accessible transportation; • Providing companion/personal support; • Reminding people of their second vaccination appointment if needed; and/or, • Providing technical assistance to local health departments or other entities on vaccine accessibility. 4. Assurance that the award recipient will do outreach to Aging and Disability Resource Centers, Centers for Independent Living, State Councils on Developmental Disabilities, and University Centers for Excellence in Developmental Disabilities Education, E:\FR\FM\09APN1.SGM 09APN1 18540 Federal Register / Vol. 86, No. 67 / Friday, April 9, 2021 / Notices Research, and Service to maximize state coordination wherever possible. 5. Assurance to provide semi-annual federal financial reports annual program reports that describes activities conducted, challenges, successes, and lessons learned. The written summary will also include number of people served or impacted by the services provided. unique identifiers of single business entities. The D–U–N–S number can be obtained from: https://iupdate.dnb.com/ iUpdate/viewiUpdateHome.htm. B. DUNS Number All grant applicants must obtain and keep current a D–U–N–S number from Dun and Bradstreet. It is a nine-digit identification number, which provides IV. Submission Information C. Intergovernmental Review Executive Order 12372, Intergovernmental Review of Federal Programs, is not applicable to these grant applications. 1. Letter of Assurance To receive funding, eligible entities must provide a Letter of Assurance P&A Program officer Alabama ............................................................. Alaska ................................................................ American Samoa ............................................... Arizona ............................................................... Arkansas ............................................................ California ............................................................ Colorado ............................................................ Connecticut ........................................................ Delaware ............................................................ District of Columbia ........................................... Florida ................................................................ Georgia .............................................................. Guam ................................................................. Hawaii ................................................................ Idaho .................................................................. Illinois ................................................................. Indiana ............................................................... Iowa ................................................................... Kansas ............................................................... Kentucky ............................................................ Louisiana ........................................................... Maine ................................................................. Maryland ............................................................ Massachusetts ................................................... Michigan ............................................................ Minnesota .......................................................... Mississippi ......................................................... Missouri ............................................................. Montana ............................................................. Native American ................................................ Nebraska ........................................................... Nevada .............................................................. New Hampshire ................................................. New Jersey ........................................................ New Mexico ....................................................... New York ........................................................... North Carolina ................................................... North Dakota ..................................................... Northern Marianas ............................................. Ohio ................................................................... Oklahoma .......................................................... Oregon ............................................................... Pennsylvania ..................................................... Puerto Rico ........................................................ Rhode Island ..................................................... South Carolina ................................................... South Dakota ..................................................... Tennessee ......................................................... Texas ................................................................. Utah ................................................................... Vermont ............................................................. Virgin Islands ..................................................... Virginia ............................................................... Washington ........................................................ West Virginia ..................................................... Wisconsin .......................................................... Elizabeth Leef ................................................... Rebecca Ellison ................................................ Elizabeth Leef ................................................... Larissa Crossen ............................................... Wilma Roberts .................................................. Dana Fink ......................................................... Wilma Roberts .................................................. Melvenia Wright ................................................ Larissa Crossen ............................................... Larissa Crossen ............................................... Elizabeth Leef ................................................... Rebecca Ellison ................................................ Elizabeth Leef ................................................... Larissa Crossen ............................................... Rebecca Ellison ................................................ Katherine Cargill-Willis ..................................... Katherine Cargill-Willis ..................................... Dana Fink ......................................................... Dana Fink ......................................................... Rebecca Ellison ................................................ Elizabeth Leef ................................................... Wilma Roberts .................................................. Wilma Roberts .................................................. Wilma Roberts .................................................. Katherine Cargill-Willis ..................................... Dana Fink ......................................................... Elizabeth Leef ................................................... Katherine Cargill-Willis ..................................... Larissa Crossen ............................................... Wilma Roberts .................................................. Dana Fink ......................................................... Larissa Crossen ............................................... Melvenia Wright ................................................ Melvenia Wright ................................................ Elizabeth Leef ................................................... Melvenia Wright ................................................ Rebecca Ellison ................................................ Katherine Cargill-Willis ..................................... Elizabeth Leef ................................................... Dana Fink ......................................................... Elizabeth Leef ................................................... Rebecca Ellison ................................................ Wilma Roberts .................................................. Melvenia Wright ................................................ Wilma Roberts .................................................. Larissa Crossen ............................................... Katherine Cargill-Willis ..................................... Dana Fink ......................................................... Elizabeth Leef ................................................... Wilma Roberts .................................................. Wilma Roberts .................................................. Melvenia Wright ................................................ Katherine Cargill-Willis ..................................... Melvenia Wright ................................................ Rebecca Ellison ................................................ Melvenia Wright ................................................ VerDate Sep<11>2014 17:45 Apr 08, 2021 Jkt 253001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 containing all the information outlined in Section III above. Letters of Assurance should be addressed to: Alison Barkoff, Acting Administrator and Assistant Secretary for Aging, Administration for Community Living, 330 C Street SW, Washington, DC 20201. Letters of Assurance should be submitted electronically via email to your ACL program officer. The following table identifies the designated program officer for each P&A: Email address Elizabeth.Leef@acl.hhs.gov. Rebecca.Ellison@acl.hhs.gov. Elizabeth.Leef@acl.hhs.gov. Larissa.Crossen@acl.hhs.gov. Wilma.Roberts@acl.hhs.gov. Dana.Fink@acl.hhs.gov. Wilma.Roberts@acl.hhs.gov. Melvenia.Wright@acl.hhs.gov. Larissa.Crossen@acl.hhs.gov. Larissa.Crossen@acl.hhs.gov. Elizabeth.Leef@acl.hhs.gov. Rebecca.Ellison@acl.hhs.gov. Elizabeth.Leef@acl.hhs.gov. Larissa.Crossen@acl.hhs.gov. Rebecca.Ellison@acl.hhs.gov. Katherine.Cargill-Willis@acl.hhs.gov. Katherine.Cargill-Willis@acl.hhs.gov. Dana.Fink@acl.hhs.gov. Dana.Fink@acl.hhs.gov. Rebecca.Ellison@acl.hhs.gov. Elizabeth.Leef@acl.hhs.gov. Wilma.Roberts@acl.hhs.gov. Wilma.Roberts@acl.hhs.gov. Wilma.Roberts@acl.hhs.gov. Katherine.Cargill-Willis@acl.hhs.gov. Dana.Fink@acl.hhs.gov. Elizabeth.Leef@acl.hhs.gov. Katherine.Cargill-Willis@acl.hhs.gov. Larissa.Crossen@acl.hhs.gov. Wilma.Roberts@acl.hhs.gov. Dana.Fink@acl.hhs.gov. Larissa.Crossen@acl.hhs.gov. Melvenia.Wright@acl.hhs.gov. Melvenia.Wright@acl.hhs.gov. Elizabeth.Leef@acl.hhs.gov. Melvenia.Wright@acl.hhs.gov. Rebecca.Ellison@acl.hhs.gov. Katherine.Cargill-Willis@acl.hhs.gov. Elizabeth.Leef@acl.hhs.gov. Dana.Fink@acl.hhs.gov. Elizabeth.Leef@acl.hhs.gov. Rebecca.Ellison@acl.hhs.gov. Wilma.Roberts@acl.hhs.gov. Melvenia.Wright@acl.hhs.gov. Wilma.Roberts@acl.hhs.gov. Larissa.Crossen@acl.hhs.gov. Katherine.Cargill-Willis@acl.hhs.gov. Dana.Fink@acl.hhs.gov. Elizabeth.Leef@acl.hhs.gov. Wilma.Roberts@acl.hhs.gov. Wilma.Roberts@acl.hhs.gov. Melvenia.Wright@acl.hhs.gov. Katherine.Cargill-Willis@acl.hhs.gov. Melvenia.Wright@acl.hhs.gov. Rebecca.Ellison@acl.hhs.gov. Melvenia.Wright@acl.hhs.gov. E:\FR\FM\09APN1.SGM 09APN1 Federal Register / Vol. 86, No. 67 / Friday, April 9, 2021 / Notices 18541 P&A Program officer Wyoming ............................................................ Katherine Cargill-Willis ..................................... Katherine.Cargill-Willis@acl.hhs.gov. 2. Submission Dates and Times To receive consideration, Letters of Assurance must be submitted by 11:59 p.m. Eastern Time on April 23, 2021. Letters of Assurance should be submitted electronically via email and have an electronic time stamp indicating the date/time submitted. and cellular and tissue-based products (HCT/Ps) regulated solely under the Public Health Service Act. ADDRESSES: You may submit either electronic or written comments at any time as follows: those filed in a timely manner (see will be placed in the docket and, except for those submitted as ‘‘Confidential Submissions,’’ publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday, 240–402–7500. • Confidential Submissions—To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ‘‘THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.’’ The Agency will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ‘‘confidential.’’ Any information marked as ‘‘confidential’’ will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure laws. For more information about FDA’s posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https:// www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf. Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https:// www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ‘‘Search’’ box and follow the prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, 240–402–7500. FOR FURTHER INFORMATION CONTACT: Victoria Wagman, Center for Biologics Evaluation and Research, Food and Drug Administration, Bldg. 71, Rm. 7301, Silver Spring, MD 20993–0002, 240–402–7911. SUPPLEMENTARY INFORMATION: VII. Agency Contacts 1. Programmatic Issues Direct programmatic inquiries to your program officer listed above or Ophelia McLain at Ophelia.mclain@acl.hhs.gov. 2. Submission Issues Direct inquiries regarding submission of the Letters of Assurance to the appropriate ACL Program Officer found in the table in ‘‘Section IV. Submission Information.’’ Dated: April 5, 2021. Alison Barkoff, Acting Administrator and Assistant Secretary for Aging. [FR Doc. 2021–07292 Filed 4–8–21; 8:45 am] BILLING CODE 4154–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2021–N–0039] Electronic Submissions; Update to the Specifications for Preparing and Submitting Postmarket Individual Case Safety Reports for Vaccines; Technical Specification AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA or Agency) Center for Biologics Evaluation and Research (CBER) is announcing the availability of version 2.2 of the Specifications for Preparing and Submitting Postmarket Individual Case Safety Reports (ICSRS) for Vaccines (Specifications). The version update is not applicable to CBER-regulated drug products marketed for human use with approved New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs); CBER-regulated therapeutic biological products marketed for human use with approved Biologic License Applications (BLAs); Whole Blood or blood components; and human cells, tissues, SUMMARY: VerDate Sep<11>2014 17:45 Apr 08, 2021 Jkt 253001 Email address Electronic Submissions Submit electronic comments in the following way: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https:// www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security Number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https:// www.regulations.gov. • If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ‘‘Written/Paper Submissions’’ and ‘‘Instructions’’). Written/Paper Submissions Submit written/paper submissions as follows: • Mail/Hand Delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. • For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ‘‘Instructions.’’ Instructions: All submissions received must include the Docket No. FDA– 2021–N–0039 for ‘‘Electronic Submissions; Update to the Specifications for Preparing and Submitting Postmarket Individual Case Safety Reports for Vaccines; Technical Specification’’. Received comments, PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 ADDRESSES), E:\FR\FM\09APN1.SGM 09APN1

Agencies

[Federal Register Volume 86, Number 67 (Friday, April 9, 2021)]
[Notices]
[Pages 18538-18541]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-07292]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration for Community Living


Availability of Program Application Instructions for the 
Protection and Advocacy Systems Network To Expand COVID-19 Vaccine 
Access for People With Disabilities

    Title: Expanding Disabilities Network's (Protection and Advocacy 
Systems) Access to COVID-19 Vaccines.
    Announcement Type: Initial.
    Statutory Authority: Subtitle C of the Developmental Disabilities 
Assistance and Bill of Rights Act of 2000 (DD Act).
    Catalog of Federal Domestic Assistance (CFDA) Number: 93.630.

DATES: The deadline date for the submission of the Expanding 
Disabilities Network's (Protection and Advocacy Systems) Access to 
COVID-19 Vaccines is 11:59 p.m. Eastern Time April 23, 2021.

SUPPLEMENTARY INFORMATION: 

I. Funding Opportunity Description

    The Administration for Community Living (ACL) announced a new 
funding opportunity to increase vaccine access for people with 
disabilities. With funding and partnership support from the Centers for 
Disease Control and Prevention (CDC), ACL is providing grants to 
disability networks to provide critical services to help communities 
combat COVID-19. A leading priority of this joint effort is to ensure 
vaccines are equally accessible to the disability population. 
Approximately 61 million adults living with in the US have a 
disability, representing approximately 26 percent of the adult 
population. People with disabilities may have an increased risk for 
contracting COVID-19 based on where they live or the services they 
receive. Some people with disabilities live in group settings, which 
places them at higher risk for acquiring COVID-19 in comparison to 
people without disabilities. People with disabilities may also require 
close contact with direct service providers, including personal care 
attendants or other care providers, who help with activities of daily 
living. Moreover, many people with disabilities have underlying health 
conditions (e.g., diabetes, heart disease, and obesity) that increases 
the risk of severe illness due to COVID-19. In addition, research also 
found that people with Down Syndrome are significantly more likely to 
be hospitalized from COVID-19 than the general population.

[[Page 18539]]

    There are increasing reports of barriers of unequal access in 
communities to vaccinate people with disabilities. For example, some 
people with disabilities may experience difficulties scheduling 
appointments, communicating, obtaining accessible transportation or 
require direct support services to attend vaccination appointments. 
Others living in the community may be isolated or unable to leave their 
home and may require in-home vaccination.
    This funding opportunity is designed to breakdown those barriers to 
expand vaccine access in communities. Examples of activities consistent 
with the purpose of this funding are the following:
     Education about the importance of receiving a vaccine;
     Identifying people unable to independently travel to a 
vaccination site;
     Helping with scheduling a vaccine appointment;
     Arranging or providing accessible transportation;
     Providing companion/personal support;
     Reminding people of the second vaccination appointment if 
needed; and/or
     Providing technical assistance to local health departments 
or other entities on vaccine accessibility.
    Awards authorized under Subtitle C of the DD Act to the Protection 
and Advocacy Systems (P&As) shall be provided funding under this 
opportunity. Award recipients will be required to submit annual 
progress reports in the form of a written summary on the activities 
conducted, challenges, successes, and lessons learned. In addition, to 
show impact of the grant awards, the grantee will include the number of 
people served or impacted by the services provided, against each of the 
activities chosen to be implemented. To be eligible to receive this 
grant, the grantee must submit a Letter of Assurance to ACL containing 
all the assurances required, (see below, ``Section III. Eligibility 
Criteria and Other Requirements'' and ``Section IV. Submission 
Information''). P&As that do not complete assurance requirements below, 
or otherwise indicate no desire to receive funds will be excluded from 
receiving funds.
    ACL may establish ad hoc dates based on the need of the COVID-19 
response, e.g., to meet unanticipated issues related to COVID-19 and/or 
to allow impacted eligible applicants that missed the cut-off date to 
submit an application for consideration. ACL intends to issue initial 
notices of award as applications are received prior to the application 
due date to address urgent COVID-19 response needs. Second notices of 
award are planned after the actual number of applicants is finalized.

II. Award Information

1. Funding Instrument Type

    These awards will be made in the form of formula grants to P&As.

2. Anticipated Total Funding per Budget Period

    Under this program announcement, ACL intends to make grant awards 
to each State, Territory, the District of Columbia, and the Native 
American Consortium. Awards made under this announcement have an 
estimated start date of April 1, 2021 and an estimated end date of 
December 31, 2022, for a 20- month budget and performance period.
    The total available funding for this opportunity is $4,000,000. 
Funding will be distributed based on the state/territory population. 
There are no cost-sharing nor match requirements.
    Below are the projected award amounts:

------------------------------------------------------------------------
                                                             Projected
                      Jurisdiction                            amount
------------------------------------------------------------------------
Alabama.................................................         $50,203
Alaska..................................................          39,713
Arizona.................................................          74,525
Arkansas................................................          39,713
California..............................................         404,556
Colorado................................................          58,963
Connecticut.............................................          39,713
Delaware................................................          39,713
District of Columbia....................................          39,713
Florida.................................................         219,907
Georgia.................................................         108,710
Hawaii..................................................          39,713
Idaho...................................................          39,713
Illinois................................................         129,744
Indiana.................................................          68,930
Iowa....................................................          39,713
Kansas..................................................          39,713
Kentucky................................................          45,744
Louisiana...............................................          47,598
Maine...................................................          39,713
Maryland................................................          61,901
Massachusetts...........................................          70,571
Michigan................................................         102,254
Minnesota...............................................          57,743
Mississippi.............................................          39,713
Missouri................................................          62,840
Montana.................................................          39,713
Nebraska................................................          39,713
Nevada..................................................          39,713
New Hampshire...........................................          39,713
New Jersey..............................................          90,943
New Mexico..............................................          39,713
New York................................................         199,181
North Carolina..........................................         107,386
North Dakota............................................          39,713
Ohio....................................................         119,683
Oklahoma................................................          40,515
Oregon..................................................          43,185
Pennsylvania............................................         131,077
Rhode Island............................................          39,713
South Carolina..........................................          52,717
South Dakota............................................          39,713
Tennessee...............................................          69,923
Texas...................................................         296,883
Utah....................................................          39,713
Vermont.................................................          39,713
Virginia................................................          87,394
Washington..............................................          77,967
West Virginia...........................................          39,713
Wisconsin...............................................          59,615
Wyoming.................................................          39,713
American Samoa..........................................          21,246
Guam....................................................          21,246
Northern Marianas.......................................          21,246
Puerto Rico.............................................          39,713
Virgin Islands..........................................          21,246
Native American.........................................          21,246
                                                         ---------------
  Total.................................................       4,000,000
------------------------------------------------------------------------

III. Eligibility Criteria and Other Requirements

1. Eligible Entities

    The eligible entity for these awards is the agency designated as a 
P&A per the DD Act.

2. Other Requirements

A. Letter of Assurance
    A Letter of Assurance is required to be submitted by the eligible 
entity in order to receive an award. The Letter of Assurance must 
include the following:
    1. Assurance that the award recipient is the agency or entity 
designated as P&A per the DD Act.
    2. Assurance that funds will supplement and not supplant existing 
P&A funding.
    3. Assurance that funds will be spent in ways consistent with the 
purpose of the funding in carrying out one or more of the following 
activities:
     Education about the importance of receiving a vaccine;
     Identifying people unable to independently travel to a 
site;
     Helping with scheduling a vaccine appointment;
     Arranging or providing accessible transportation;
     Providing companion/personal support;
     Reminding people of their second vaccination appointment 
if needed; and/or,
     Providing technical assistance to local health departments 
or other entities on vaccine accessibility.
    4. Assurance that the award recipient will do outreach to Aging and 
Disability Resource Centers, Centers for Independent Living, State 
Councils on Developmental Disabilities, and University Centers for 
Excellence in Developmental Disabilities Education,

[[Page 18540]]

Research, and Service to maximize state coordination wherever possible.
    5. Assurance to provide semi-annual federal financial reports 
annual program reports that describes activities conducted, challenges, 
successes, and lessons learned. The written summary will also include 
number of people served or impacted by the services provided.
B. DUNS Number
    All grant applicants must obtain and keep current a D-U-N-S number 
from Dun and Bradstreet. It is a nine-digit identification number, 
which provides unique identifiers of single business entities. The D-U-
N-S number can be obtained from: https://iupdate.dnb.com/iUpdate/viewiUpdateHome.htm.
C. Intergovernmental Review
    Executive Order 12372, Intergovernmental Review of Federal 
Programs, is not applicable to these grant applications.

IV. Submission Information

1. Letter of Assurance

    To receive funding, eligible entities must provide a Letter of 
Assurance containing all the information outlined in Section III above.
    Letters of Assurance should be addressed to: Alison Barkoff, Acting 
Administrator and Assistant Secretary for Aging, Administration for 
Community Living, 330 C Street SW, Washington, DC 20201.
    Letters of Assurance should be submitted electronically via email 
to your ACL program officer. The following table identifies the 
designated program officer for each P&A:

------------------------------------------------------------------------
               P&A                  Program officer      Email address
------------------------------------------------------------------------
Alabama.........................  Elizabeth Leef....  [email protected].
Alaska..........................  Rebecca Ellison...  [email protected].
American Samoa..................  Elizabeth Leef....  [email protected].
Arizona.........................  Larissa Crossen...  [email protected].
Arkansas........................  Wilma Roberts.....  [email protected].
California......................  Dana Fink.........  [email protected].
Colorado........................  Wilma Roberts.....  [email protected].
Connecticut.....................  Melvenia Wright...  [email protected].
Delaware........................  Larissa Crossen...  [email protected].
District of Columbia............  Larissa Crossen...  [email protected].
Florida.........................  Elizabeth Leef....  [email protected].
Georgia.........................  Rebecca Ellison...  [email protected].
Guam............................  Elizabeth Leef....  [email protected].
Hawaii..........................  Larissa Crossen...  [email protected].
Idaho...........................  Rebecca Ellison...  [email protected].
Illinois........................  Katherine Cargill-  Katherine.Cargill-
                                   Willis.             [email protected]
                                                       v.
Indiana.........................  Katherine Cargill-  Katherine.Cargill-
                                   Willis.             [email protected]
                                                       v.
Iowa............................  Dana Fink.........  [email protected].
Kansas..........................  Dana Fink.........  [email protected].
Kentucky........................  Rebecca Ellison...  [email protected]cl.hhs.gov.
Louisiana.......................  Elizabeth Leef....  [email protected].
Maine...........................  Wilma Roberts.....  [email protected].
Maryland........................  Wilma Roberts.....  [email protected].
Massachusetts...................  Wilma Roberts.....  [email protected].
Michigan........................  Katherine Cargill-  Katherine.Cargill-
                                   Willis.             [email protected]
                                                       v.
Minnesota.......................  Dana Fink.........  [email protected].
Mississippi.....................  Elizabeth Leef....  [email protected].
Missouri........................  Katherine Cargill-  Katherine.Cargill-
                                   Willis.             [email protected]
                                                       v.
Montana.........................  Larissa Crossen...  [email protected].
Native American.................  Wilma Roberts.....  [email protected].
Nebraska........................  Dana Fink.........  [email protected].
Nevada..........................  Larissa Crossen...  [email protected].
New Hampshire...................  Melvenia Wright...  [email protected].
New Jersey......................  Melvenia Wright...  [email protected].
New Mexico......................  Elizabeth Leef....  [email protected].
New York........................  Melvenia Wright...  [email protected].
North Carolina..................  Rebecca Ellison...  [email protected].
North Dakota....................  Katherine Cargill-  Katherine.Cargill-
                                   Willis.             [email protected]
                                                       v.
Northern Marianas...............  Elizabeth Leef....  [email protected].
Ohio............................  Dana Fink.........  [email protected].
Oklahoma........................  Elizabeth Leef....  [email protected].
Oregon..........................  Rebecca Ellison...  [email protected].
Pennsylvania....................  Wilma Roberts.....  [email protected].
Puerto Rico.....................  Melvenia Wright...  [email protected].
Rhode Island....................  Wilma Roberts.....  [email protected].
South Carolina..................  Larissa Crossen...  [email protected].
South Dakota....................  Katherine Cargill-  Katherine.Cargill-
                                   Willis.             [email protected]
                                                       v.
Tennessee.......................  Dana Fink.........  [email protected].
Texas...........................  Elizabeth Leef....  [email protected].
Utah............................  Wilma Roberts.....  [email protected].
Vermont.........................  Wilma Roberts.....  [email protected].
Virgin Islands..................  Melvenia Wright...  [email protected].
Virginia........................  Katherine Cargill-  Katherine.Cargill-
                                   Willis.             [email protected]
                                                       v.
Washington......................  Melvenia Wright...  [email protected].
West Virginia...................  Rebecca Ellison...  [email protected].
Wisconsin.......................  Melvenia Wright...  [email protected].

[[Page 18541]]

 
Wyoming.........................  Katherine Cargill-  Katherine.Cargill-
                                   Willis.             [email protected]
                                                       v.
------------------------------------------------------------------------

2. Submission Dates and Times

    To receive consideration, Letters of Assurance must be submitted by 
11:59 p.m. Eastern Time on April 23, 2021. Letters of Assurance should 
be submitted electronically via email and have an electronic time stamp 
indicating the date/time submitted.

VII. Agency Contacts

1. Programmatic Issues

    Direct programmatic inquiries to your program officer listed above 
or Ophelia McLain at [email protected].

2. Submission Issues

    Direct inquiries regarding submission of the Letters of Assurance 
to the appropriate ACL Program Officer found in the table in ``Section 
IV. Submission Information.''

    Dated: April 5, 2021.
Alison Barkoff,
Acting Administrator and Assistant Secretary for Aging.
[FR Doc. 2021-07292 Filed 4-8-21; 8:45 am]
BILLING CODE 4154-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.